Ava Strong: One Mom’s Journey to Advocate for Better Childhood Cancer Treatments

From the time she wakes up to the time she goes to sleep, Ava is talking, singing, and dancing. She is a joyful, active child who loves to paint, color, and make crafts. Her world changed when at only four years old she started having frequent bouts of morning vomiting, which doctors thought could be from acid reflux or abdominal migraines. She later developed a localized headache in the back of her head. The headache prevented Ava from wanting to participate in her favorite activities; instead, she would spend most of her time laying down. One night her mother Kassi noticed Ava’s balance was off and decided to take her to the emergency room.

A CT scan revealed a halo orange-sized tumor in the back of Ava’s cerebellum. Three days later she had surgery to remove the medulloblastoma tumor.

Medulloblastoma has four subtypes and Ava’s tumor was group 3, the most aggressive form. Her family was grateful the tumor did not spread, and all the tumor was removed. However, she still required an aggressive approach to treatment. This led Ava to Children’s National Hospital to begin 6 weeks of chemotherapy and radiation, then 6 months of high-dose chemotherapy at Children’s Hospital of Richmond. She stopped treatment in June 2022 and her recent 3-month post-treatment MRI showed no evidence of disease.

Since Ava was diagnosed with brain cancer, her mom Kassi has used the power of social media to provide updates to their community and spread awareness. She started posting on Instagram and Facebook as a way to limit the overwhelming feelings that come with reliving the situation, but later became a space to advocate for other kids like Ava.

Children with brain cancer can’t wait another week, another day, another minute for your support. When you donate to the Pediatric Brain Tumor Foundation, you help fund life-changing research and provide families with the resources and support they need. Don’t let pediatric brain cancer steal another future.

“Ava Strong started when she was first diagnosed. When you first enter this world, it is very overwhelming, and everyone wants to know what’s going on. I created the Instagram and Facebook accounts to have one source for anyone who wanted to know information. As people stumbled upon the Instagram and I grew stronger and angrier with the information, it became more of a platform for me to voice important issues,” says Kassi.

One way Kassi used the Ava Strong platform was by reaching out to celebrities to amplify the need for more childhood brain cancer research. Only one person responded—Emmy award-winning broadcast journalist, Anderson Cooper. His response was simple. He asked “what can I do?”

Kassi asked if Anderson would be willing to share their page to help spread awareness. He wanted to do more and asked to interview both Kassi and Ava about her pediatric brain tumor journey, the lack of funding that goes towards childhood cancer research, and the harsh reality of childhood cancer because of the outdated treatment options.

In his interview with Kassi and Ava, Anderson shared that he was ignorant on this topic and thought “kids must get the most cutting-edge treatment, and there must be huge research to be done in how to save the most innocent among us.” But he learned the complete opposite is true. Pharmaceutical companies aren’t incentivized to research and develop new drugs for the many rare types of pediatric cancers and government funding mainly benefits adult patients.

“If research is going to be done for these kids, it’s going to be through foundations like the Pediatric Brain Tumor Foundation,” shares Kassi. “It takes people getting involved with these types of organizations to get the funding we need.”

This May marks the second Brain Tumor Awareness Month since Ava’s cancer journey began. While she’s able to embrace every second of her life right now, her family knows other kids with brain cancer won’t get that opportunity.

With each passing day, more children are diagnosed and dying from the deadliest childhood disease. More families are mourning the loss of futures that will never be fulfilled.

Kids like Ava can’t wait another year, another month, another day for your support. Don’t wait until May – donate today and give kids with brain cancer the futures they deserve.

Related Stories

Pediatric Brain Tumors Shouldn’t Be Ignored Because They're Uncomfortable to Talk About

Pediatric Brain Tumors Shouldn’t Be Ignored Because They're Uncomfortable to Talk About

My brain tumor experience is something I think about every day of my life, but the outside world likes to erase that and pretend it didn’t happen. It’s too “taboo” or “uncomfortable.” So, this year, on the 7th anniversary of my surgery, I want to talk about it.

Valentina: Living with Pediatric Low-Grade Glioma

Valentina: Living with Pediatric Low-Grade Glioma

In June 2018, Valentina was diagnosed with a pediatric low-grade glioma with a BRAF mutation. At the time, she was only one year old. Surgery was not an option, so her family had two choices for treatment—traditional chemotherapy or an experimental treatment suitable for her type of mutation.

Zoe: A Pediatric Brain Tumor Survivor’s Love of Books Opens the Door to New Research Funding

Zoe: A Pediatric Brain Tumor Survivor’s Love of Books Opens the Door to New Research Funding

Combining her love for reading and desire to give back to help kids with brain tumors like her, Zoe created Books 4 Brains to raise money for pediatric brain cancer research. Join her upcoming Books 4 Brains read-a-thon and support the Pediatric Brain Tumor Foundation's research funding efforts.

Related Updates

Pediatric Brain Tumor Foundation Celebrates FDA Approval of Day One Biopharmaceuticals’ OJEMDA

Drug Development News

Pediatric Brain Tumor Foundation Celebrates FDA Approval of Day One Biopharmaceuticals’ OJEMDA

The FDA has approved Day One Biopharmaceuticals’ OJEMDA (tovorafenib) for treating pediatric low-grade glioma (pLGG), the most common brain tumor diagnosed in children. The availability of this first-of-its-kind treatment represents an important, long-awaited moment for many pLGG patients. It also marks a significant milestone in the Pediatric Brain Tumor Foundation’s efforts to accelerate new treatment options for all children with brain tumors.

Pediatric Brain Tumor Foundation Awards More Than $1 Million in New Research Funding to Dana-Farber Cancer Institute

Research News

Pediatric Brain Tumor Foundation Awards More Than $1 Million in New Research Funding to Dana-Farber Cancer Institute

The Pediatric Brain Tumor Foundation (PBTF) proudly announces an infusion of $1 million to help researchers, led by Dana-Farber Cancer Institute’s Drs. Pratiti (Mimi) Bandopadhayay and Rameen Beroukhim, launch a study into a novel therapeutic target and expand their research into overcoming treatment resistance and rebound growth.

Related Resources

Name(Required)
This field is for validation purposes and should be left unchanged.